Latest Publications

Share:

DAMITT Q2 2024: Abandonments Dominate the Podium in Merger Enforcement

The U.S. agencies concluded 11 significant merger investigations in the first half of 2024—just one shy of the total concluded in all of 2023. Activity has picked up considerably since last year but is still below the...more

DAMITT Q1 2024: Merger Enforcement Begins 2024 with a Bang

The U.S. agencies announced the conclusion of six significant merger investigations in Q1 2024, double the number seen last quarter. This marks the end of six quarters of three or fewer significant investigations. In line...more

DAMITT 2023 Annual Report: Minding the Gap in Merger Enforcement

Only 12 significant merger investigations concluded in 2023—a drop of 40 percent from just last year and by far the lowest in DAMITT history. This observed and verifiable drop sharply contrasts with recent reports that...more

DAMITT Q3 2023: Merger Control Is a Marathon, Not a Sprint

United States - All significant U.S. merger investigations concluded in either a complaint or an abandoned transaction. Four of the last five quarters have now concluded without any consent agreements, demonstrating the...more

DAMITT Q2 2023: When Avoiding Settlements, Does Merger Enforcement Settle for Less?

All significant U.S. merger investigations concluded in either a complaint or an abandoned transaction. Three of four quarters over the last year have now concluded without any consent agreements, demonstrating the agencies’...more

New EU Guidelines: Agreements Among Competitors

The European Commission has published new guidance and related regulations concerning cooperation among competitors, under Article 101 of the Treaty on the Functioning of the European Union (TFEU). These replace instruments...more

DAMITT 2022 Annual Report: Timing and Remedy Risks Grow for Transactions Hit with Significant Investigations

Sixty percent of significant investigations concluded with a complaint or abandoned transaction in 2022. This shatters last year’s record of 37 percent. The 10 complaints filed in 2022 are also a DAMITT record. Those are...more

DAMITT Q3 2022: Merger Enforcement Remains Aggressive Despite U.S. Court Losses

Key Facts - United States - • Only three significant merger investigations concluded in Q3 2022. All three investigations ended with a complaint or an abandoned transaction. For the first time in more than a decade,...more

The entry into force of the Digital Markets Act kicks off new era of digital regulation in Europe

On 12 October the Digital Markets Act (DMA)1  was published in the Official Journal of the European Union. The DMA will enter into force on 1 November 2022 and will apply as of 2 May 2023. The DMA introduces European-wide ex...more

EU Clears Way for New Foreign Subsidies Regime

On June 30, 2022, the EU institutions reached a political agreement on the text for the FSR that will give far-reaching powers to the EC to control subsidies provided by non-EU governments to businesses active in the EU....more

Dechert Cyber Bits - Issue 18

Federal Privacy Bill (ADPPA) is Sent to the House Floor but Obstacles to its Passage Remain - On July 20, 2022, the House Committee on Energy and Commerce (“the Committee”) voted 53-2 in favor of advancing The American Data...more

DAMITT Q2 2022: Is Merger Enforcement Taking a Conservative Turn?

In both our DAMITT 2021 Report and our Q1 2022 Report, we warned that parties to transactions subject to significant merger investigations were more likely to see the FTC or DOJ sue to block their deal or push them to abandon...more

DAMITT Q1 2022: Significant Merger Investigations Face Steeper Hurdles to Settlement

In the U.S., “significant” merger investigations include Hart-Scott-Rodino (HSR) Act reportable transactions for which the result of the investigation by the Federal Trade Commission (FTC) or the Antitrust Division of the...more

DAMITT 2021 Report: Merger Investigation Activity Sinks More Deals

The number of significant U.S. merger investigations concluded in the first year of the Biden administration was in line with the average observed during the Trump administration....more

Dechert Cyber Bits - Issue 4

EDPB Issues Draft Guidance on International Data Transfers - On November 18, 2021, the European Data Protection Board (“EDPB”) published draft guidance on the interaction between the GDPR’s transfer provisions set out in...more

DAMITT Q3 2021: Where’s the Wave? No Uptick Yet in Significant Merger Enforcement Activity

Key Facts - United States - Dechert has yet to see an increase in concluded significant U.S. merger investigations despite a surge in merger filings that began in the fall of 2020. Instead, we continue to see a decrease in...more

DAMITT Q2 2021: Move Over Big Tech – Traditional Industries See More Merger Investigation Activity

Key facts - United States - Despite Big Tech headlines, the percentage of significant U.S. merger investigations involving technology companies was below the average for the last decade. By contrast, merger investigations in...more

Baked & Wired: Potential Break in Impasse Over e-Privacy Regulation

On 10 February 2021, over two and a half years after the anticipated adoption of the e-Privacy Regulation, European Member States have agreed to a revised text. Portending a potential break in the three-year impasse, the...more

UK Life Sciences and Healthcare Newsletter - December 2020: Market News

Recent notable industry transactions. The Alan Turing Institute, the Royal Statistical Society and the UK Department of Health and Social Care's Joint Biosecurity Centre finalised a partnership agreement in relation to the...more

UK Life Sciences and Healthcare Newsletter- December 2020: Regulatory Updates

Medicines and Medical Devices Bill (MMDB) – The MMDB is intended to act as the primary UK legislation specifying powers that would enable the regulatory regimes for human medicines, clinical trials, veterinary medicines and...more

UK Life Sciences and Healthcare Newsletter - December 2020: A Brief Update on the EMI Scheme

As the most tax advantageous HMRC approved share option scheme available, the Enterprise Management Incentive (EMI) scheme has long been the preferred form of incentive for eligible early and mid-stage UK-based life science...more

UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill

The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and...more

DAMITT Q3 2020: Trump/Biden U.S. Election Antitrust Preview; End of Brexit Transition Period in Sight

The Dechert Antitrust Merger Investigation Timing Tracker (DAMITT) is a quarterly release from Dechert LLP reporting on trends in significant merger control investigations in the United States (U.S.) and European Union...more

33 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide